Now, the pharmaceutical industry is increasingly adopting stem cells for testing the toxicity of drugs and identifying potential new therapies, say those in the field.
Despite the EU's 2009 ban, cosmetics firms were allowed to continue testing on animals for the most complex human health effects, such as toxicity which might lead to cancer.